Showing results (81-90 of 146) with videos related to
Sort By:
Pageof 15
Oncotarget|April 7, 2016
BCL2-BH4 antagonist BDA-366 suppresses human myeloma growthJiusheng Deng, Dongkyoo Park, Mengchang Wang, et al.Genome Research|February 4, 2012
Age-associated DNA methylation in pediatric populationsReid S Alisch, Benjamin G Barwick, Pankaj Chopra, et al.Journal of Immunology (Baltimore, Md. : 1950)|November 30, 2016
Conserved Region C Functions To Regulate PD-1 Expression and Subsequent CD8 T Cell MemoryAlexander P R Bally, Yan Tang, Joshua T Lee, et al.Epigenetics|April 16, 2016
Factors affecting the persistence of drug-induced reprogramming of the cancer methylomeJoshua S K Bell, Jacob D Kagey, Benjamin G Barwick, et al.Blood|April 10, 2014
MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cellsYanyan Gu, Jonathan L Kaufman, Leon Bernal, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 17, 2021
The Murine MHC Class II Super Enhancer IA/IE-SE Contains a Functionally Redundant CTCF-Binding Component and a Novel Element Critical for Maximal ExpressionParimal Majumder, Joshua T Lee, Benjamin G Barwick, et al.Journal of Immunology (Baltimore, Md. : 1950)|December 8, 2019
PD-1 Expression during Acute Infection Is Repressed through an LSD1-Blimp-1 AxisAlexander P R Bally, Dennis K Neeld, Peiyuan Lu, et al.Blood|September 17, 2010
Tipifarnib sensitizes cells to proteasome inhibition by blocking degradation of bortezomib-induced aggresomesEbenezer David, Jonathan L Kaufman, Christopher R Flowers, et al.Cancer Biology & Therapy|June 2, 2016
Dual inhibition of Mcl-1 by the combination of carfilzomib and TG02 in multiple myelomaKatelyn G Ponder, Shannon M Matulis, Sadae Hitosugi, et al.Blood|June 11, 2011
Distribution of Bim determines Mcl-1 dependence or codependence with Bcl-xL/Bcl-2 in Mcl-1-expressing myeloma cellsAlejo A Morales, Metin Kurtoglu, Shannon M Matulis, et al.Pageof 15